Skip to content

Trial of induction of labour by oral drug in late intrauterine fetal death

Comparative study of Mifepristone alone versus Mifepristone and Misoprostol combination for Induction of labour in Late intrauterine fetal death

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053692
Enrollment
80
Registered
2023-06-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Induction of Labour: Tablet Mifepristone 200mg orally thrice a day for max 2 days, for induction of labour in late intrauterine fetal death Control Intervention1: Induction of labour: T

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pregnant women with age more than 18 years 2. Gestational age more than equal to 28 weeks 3. Singleton pregnancy 4. Not in labour 5. Ultrasonographically confirmed intrauterine fetal death

Exclusion criteria

Exclusion criteria: 1. Multiple gestation 2. Abnormal coagulation profile 3. Contraindication for Prostaglandins 4. History of uterine surgery 5. Antepartum haemorrhage 6. Patients already in labour 7. Patients on concurrent Anticoagulants 8. Inherited porphyrias 9. Any contraindication for vaginal delivery

Design outcomes

Primary

MeasureTime frame
1. To know effect of both regimens for induction of labour in terms of cervical dilatation 2. Compare induction to delivery interval in both regimensTimepoint: 1. Induction to delivery interval

Secondary

MeasureTime frame
1. To know percentage of failure cases in both these groups 2. To compare drug related side effects in both regimens 3. To evaluate need of augmentation with oxytocinTimepoint: 2 days

Countries

India

Contacts

Public ContactDr Seema Rawal

DR BABA SAHEB AMBEDKAR MEDICAL COLLEGE AND HOSPITAL, ROHINI SEC 06, DELHI

seemapundir2014@gmail.com9654278803

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026